Life Science Investing Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates
Life Science Investing Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
Life Science Investing Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares
